Biocide TRIZ Cases

Substituted gamma lactam compounds act as prostaglandin EP2 agonists to treat ocular and dermatological conditions.

Aminopyrimidine derivatives target Syk-mediated pathways to treat asthma, rheumatoid arthritis, and cancer.

A flowable drug composition transitions to a non-flowable state upon physiological contact.

A hydrophobic silica dispersion formulation utilizes deaeration to remove entrained air and improve stability.

Formula I ether compounds improve pest control efficacy by optimizing molecular substituents to resolve the trade-off between potency and specificity.

A treatment agent combines titanium oxide photocatalysis with sodium polyacrylate adsorption to remove biological contaminants from surfaces.

Trioxolane prodrugs react with elevated ferrous iron in cancer cells or malaria parasites to release active drug species, reducing systemic toxicity.

Inoculating grapevines with benign Xylella fastidiosa strains induces systemic resistance against virulent pathogens.

LR-90 reduces renal injury markers and oxidative stress by blocking non-enzymatic glycation, addressing treatment limits in subjects with multiple risk factors.

Biologically active thiazolidinedione compounds improve tissue fuel metabolism.

A synergistic herbicidal composition combines pyroxsulam and sulfosulfuron to deliver enhanced weed control efficacy in cereal crops.

Adjusting omega-6 to omega-3 ratios from 1:1 to 4:1 improves skin health and pelage quality while preventing excessive shedding.

Heating aluminium sesquichlorohydrate with calcium salts and amino acids creates an activated complex that reduces Staphylococci bacterial numbers.

Quaternary ammonium salts preserve polymer emulsions against microbial biodeterioration while reducing toxicity and resistance risks.

A herbicidal composition combines a pyridine carboxylic acid derivative with an auxin transport inhibitor to enhance weed control efficacy.

Fatty acid additives in the imiquimod cream accelerate drug permeation through the skin barrier, reducing treatment duration and minimizing irritation.

A cationic polymer film inactivates pathogens through electrostatic membrane disruption and chemical denaturation.

Formula I compound forms a stable covalent adduct with catalytic lysine residues, permanently inactivating DNA polymerase beta lyase activity.

Combining iron compounds with low-concentration metaldehyde reduces active ingredient consumption while maintaining high mollusc mortality rates.

Composite material design resolves the contradiction between solubility and stability, enabling effective type 2 diabetes treatment.

N-benzylindole compounds block cdk5-mediated phosphorylation of PPARG, avoiding weight gain and cardiac hypertrophy associated with agonists.

Combining 1-methylpyrazole-4-ylcarboxylic acid anilides with azolopyrimidinylamines creates synergistic fungicidal compositions.

Botanical sabadilla oil suppresses fungal pathogens like rust and mildew while reducing environmental pollution from synthetic chemicals.

A decontamination composition neutralizes capsaicinoids using surfactants and chelating agents, resolving inconsistent pepper spray performance.

Betel leaf extract composition combines specific plant compounds to achieve 99.99% bactericidal efficiency without toxicity.

Systematic parameter changes to the heterocyclic core enhance biological efficacy while maintaining crop plant tolerance.

Composite surfactant systems form lamellar liquid crystal coatings around oil globules to prevent Ostwald ripening and extend shelf life.

Halogenated furanone copolymers inhibit bacterial quorum sensing through polymerization on medical device surfaces.

Monoamine oxidase inhibitors increase neurotransmitter levels to promote hair growth, avoiding side effects from conventional treatments.

A composite collagen carrier maintains microspheres in suspension at body temperature.

Lactic acid esters and non-ionic surfactants stabilize lipophilic terpenes in aqueous sprays, preventing phase separation and equipment blockage.

IAB/BS03 Bacillus subtilis strain delivers potent antifungal activity through antibiotic production and resource competition mechanisms.

Incorporating a base shifts the pH to 7.5–12, stabilizing mesotrione in solid compositions and preventing acidic decomposition.

Amide compounds activate glucokinase to enhance insulin secretion, addressing inadequate blood glucose control in Type II diabetes treatment.

Photoactive polymer enables controlled metallic nanoparticle immobilization, resolving trade-offs between antibacterial reliability and process versatility.

A polycarboxylic acid derivative combined with an essential oil and biosurfactant disrupts preformed biofilms.

Chamomile extract reduces eye irritation from conventional agents while maintaining cleaning and disinfecting capabilities.

A sulfur-containing compound inhibits inducible nitric oxide synthase and cyclooxygenase-2 enzymes through targeted chemical interaction.

Applying a vasoconstrictor before an anti-acne agent reduces outflow from acne lesions, maintaining higher local concentrations of active ingredients.

Hydrogenated phospholipids replace silicone surfactants in alcohol-based disinfectant foam to prevent skin barrier disruption and environmental harm.

Solutol HS15 replaces polysorbate 80 to stabilize prostaglandins for 18 months, eliminating benzalkonium chloride toxicity risks.

Non-anticoagulant sulfated polysaccharides accelerate blood coagulation by inhibiting Tissue Factor Pathway Inhibitor activity.

Starch mediates attrition of slippery hydrocolloids with microcrystalline cellulose to prevent agglomeration and achieve superior gel strength.

Chiral HPLC separation isolates the active 6R,7R zilpaterol enantiomer to reduce μ-opioid receptor affinity and side effects.